Cargando…
In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of β-amyloid plaques associated with Alzheimer's disease
BACKGROUND: Alzheimer's disease, known to be associated with the gradual loss of memory, is characterized by low concentration of acetylcholine in the hippocampus and cortex part of the brain. Inhibition of acetylcholinesterase has successfully been used as a drug target to treat Alzheimer'...
Autores principales: | Ul-Haq, Zaheer, Khan, Waqasuddin, Kalsoom, Saima, Ansari, Farzana L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905356/ https://www.ncbi.nlm.nih.gov/pubmed/20550720 http://dx.doi.org/10.1186/1742-4682-7-22 |
Ejemplares similares
-
Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE
por: Magar, Pratibha, et al.
Publicado: (2021) -
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018) -
Characterization
of the Transient Oxaphosphetane BChE
Inhibitor Formed from Spontaneously Activated Ethephon
por: Lantz, Stephen R., et al.
Publicado: (2013) -
In Vitro and In Silico Investigation of Polyacetylenes from Launaea capitata (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors
por: Abdel Bar, Fatma M., et al.
Publicado: (2023) -
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids
por: Guimarães, Larissa O., et al.
Publicado: (2014)